期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 71, 期 20, 页码 3885-3901出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-014-1656-6
关键词
Histone deacetylases (HDACs); Histone deacetylase inhibitor (HDACi); Cell death; Apoptosis; Autophagy
资金
- Welch Foundation
- Ellison Medical foundation
- American Cancer Society [RSG-11-274-01-CCG]
- NIH R01 [CA133228]
Histone deacetylases (HDACs) are a vast family of enzymes involved in chromatin remodeling and have crucial roles in numerous biological processes, largely through their repressive influence on transcription. In addition to modifying histones, HDACs also target many other non-histone protein substrates to regulate gene expression. Recently, HDACs have gained growing attention as HDAC-inhibiting compounds are being developed as promising cancer therapeutics. Histone deacetylase inhibitors (HDACi) have been shown to induce differentiation, cell cycle arrest, apoptosis, autophagy and necrosis in a variety of transformed cell lines. In this review, we mainly discuss how HDACi may elicit a therapeutic response to human cancers through different cell death pathways, in particular, apoptosis and autophagy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据